HOME > BUSINESS
BUSINESS
- Renascience to Welcome Former MHLW Director as EVP
May 28, 2025
- Lilly/NCNP Tie Up for Research on APOE Gene Testing
May 27, 2025
- Decline of Obesity Population Might Curb Rise in Healthcare Costs: Lilly
May 27, 2025
- Mitsubishi Tanabe Taps Moderna’s Nagayama as New EVP Post
May 27, 2025
- Moderna Launches Prefilled Version of Spikevax in Japan
May 27, 2025
- Sun Pharma Japan Eyes 10%-Plus CAGR as It Pivots to New Drug Biz
May 26, 2025
- Santen Aims to Net 400 Billion Yen in FY2029 Riding on Myopia, Droopy Eyelid Drugs
May 26, 2025
- Novartis Keen to Ensure Stable Supply of Radioligand Therapies in Japan
May 26, 2025
- Pfizer Files Anaemetro’s Pediatric Use; Coverage Already Granted
May 26, 2025
- Japan Pharma Market Grows 1% to Record 11.4 Trillion Yen in FY2024: IQVIA
May 23, 2025
- Tecentriq-Avastin Yields Positive Data on HCC: China/Japan PIII
May 23, 2025
- Meiji, Sandoz Tie-Up to Secure Stable Supply of Antibiotic Intermediates
May 23, 2025
- Camzyos, Tremfya, Tivdak, and More Now Available in Japan
May 22, 2025
- Alloy Japan Now Up and Running to Deliver iCAR-T for Cancer Therapy Development
May 22, 2025
- MSD Chief Decries Japan’s Unpredictable Policy Flip, Frets Future Investment
May 22, 2025
- Gilead Seeks Lawmakers’ Backing for Public Subsidies in PrEP
May 21, 2025
- Hiroaki Ueno to Retire as Representative Director of Mitsubishi Tanabe
May 21, 2025
- Sanofi Japan Seeing Improved Customer Satisfaction with AI-Powered Sales Support Tool
May 21, 2025
- 25 Japan Drug Makers’ Total Operating Profit Tops 2 Trillion Yen for 1st Time: Tally
May 20, 2025
- Chugai’s PNH Drug PiaSky Approved in Taiwan
May 20, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
